http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0474517-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59
filingDate 1991-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dc5132b601c6c0278b0c7c1398510a3
publicationDate 1998-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0474517-B1
titleOfInvention Novel use of 1alpha-hydroxylated-19-nor-vitamin D compounds to treat psoriasis
abstract A novel use for 1 alpha -hydroxylated-19-nor-vitamin D compounds to treat psoriasis inasmuch as these compounds when administered to humans are converted to a metabolite, such as a 1 alpha ,25-dihydroxylated compound, which metabolite in vitro will cause differentiation in a human cell line.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9295928-B2
priorityDate 1990-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87070941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87065662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406008
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129394664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87058084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87060437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128732752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12303103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226509607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129668460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9898815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128185245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226659712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127445436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129559476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128481862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87091364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71308193

Total number of triples: 57.